The multi-center, pivotal DISTALS trial is enabled by TIGERTRIEVER™ 13, the smallest and only thrombectomy device designed for distal vessels YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–#DISTALS—Rapid Medical, a leading developer of advanced neurovascular devices, announced today the enrollment of the first patient in the DISTALS Study. The trial is the first-ever FDA investigational device exemption (IDE) … [Read more…]

SANTA FE, N.M.–(BUSINESS WIRE)–Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under which Specifica’s patented Generation 3 Antibody Discovery Platform will be transferred to Sanofi. The comprehensive technology transfer package will enable the integration of Specifica’s … [Read more…]

Company’s web-based platform empowers researchers to integrate, process, and visualize biological data in one place, shortening timelines from experiment to results SAN FRANCISCO–(BUSINESS WIRE)–#AI–LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series A round co-led … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Additive Technology Markets for Engineered Solid Dosage Forms” report has been added to ResearchAndMarkets.com’s offering. 3D printing (3DP) or additive manufacturing (AM) is a family of technologies that implement layer-by-layer processes in order to fabricate physical models, based on a computer aided design (CAD) model. 3D printing permits the fabrication of high degrees … [Read more…]

mAbxience secures its second 4,000L ABEC Custom Single Run (CSR®) bioreactor to increase manufacturing capacity at its Leon, Spain facility BETHLEHEM, Pa.–(BUSINESS WIRE)–#ABEC—ABEC, a global provider of engineered solutions and services for biotech manufacturing, today announced that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an additional ABEC 4,000L CSR bioreactor. Following … [Read more…]

‘VecTabs’ developed using VectorY’s proprietary platform show positive effect on key drivers of ALS pathology AMSTERDAM–(BUSINESS WIRE)–VectorY, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neurodegenerative and muscular disorders through vectorized antibodies, today announced new data at the 2022 ENCALS meeting in Edinburgh. The poster, which was … [Read more…]

– Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership … [Read more…]

Kai.ai longitudinal and retrospective studies are accepted for publication in the Journal of Medical Internet Research for peer review NEW YORK–(BUSINESS WIRE)–#mentalhealth—Kai.ai, the market leader in AI-based technology for mental health and well-being care to adolescents, has announced that two of its research papers have been accepted for publication by The Journal of Medical Internet … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Glucose Biosensors Market Size, Share & Trends Analysis Report by Type (Electrochemical, Optical, Others), by End Use (Hospitals, Homecare, Diagnostic centers), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global glucose biosensor market size is expected to reach USD 20.1 billion by 2030. The market is expected … [Read more…]

100% of millennials achieved greater than 1-point improvement on the Glabellar Line Scale on days 7, 14 and 30 100% of millennials were satisfied or very satisfied with treatment on days 7 and 30 Jeuveau® found to be well-tolerated by both millennials and non-millennials NEWPORT BEACH, Calif.–(BUSINESS WIRE)–$EOLS–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company … [Read more…]